Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
60,582,473
-
Share change
-
+1,052,393
-
Total reported value
-
$4,347,765,110
-
Put/Call ratio
-
186%
-
Price per share
-
$71.75
-
Number of holders
-
422
-
Value change
-
+$28,865,882
-
Number of buys
-
166
-
Number of sells
-
240
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2018
As of 31 Dec 2018,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
422 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,582,473 shares.
The largest 10 holders included
UBS Group AG, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, BNP PARIBAS ARBITRAGE, SA, WELLS FARGO & COMPANY/MN, DEUTSCHE BANK AG\, and BARCLAYS PLC.
This page lists
422
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.